IGM Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
08 Mar
<a href="https://laohu8.com/S/IGMS">IGM Biosciences</a> Inc reports results for the quarter ended December 31 - Earnings Summary
  • IGM Biosciences Inc IGMS.OQ reported a quarterly adjusted loss of 61 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-1.01. The mean expectation of ten analysts for the quarter was for a loss of 74 cents per share. Wall Street expected results to range from -93 cents to -57 cents per share.

  • Revenue fell 36.7% to $412.00 thousand from a year ago; analysts expected $393.75 thousand.

  • IGM Biosciences Inc's reported EPS for the quarter was a loss of 61 cents​.

  • The company reported a quarterly loss of $36.65 million.

  • IGM Biosciences Inc shares had fallen by 77.1% this quarter.

FORECAST CHANGES

  • The mean earnings estimate of analysts had risen by about 5.1% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 9 "hold" and 1 "sell" or "strong sell."

  • The average consensus recommendation for the biotechnology & medical research peer group is also "hold"

Wall Street's median 12-month price target for IGM Biosciences Inc is $2.00

This summary was machine generated from LSEG data March 7 at 05:09 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Dec. 31 2024

-0.74

-0.61

Beat

Sep. 30 2024

-0.80

-1.01

Missed

Jun. 30 2024

-0.04

-0.79

Missed

Mar. 31 2024

-0.83

-0.83

Met

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10